POSTED: April 20, 2016

Zocere at Innovate New Mexico Technology Showcase

Zocere will be the upcoming Innovate New Mexico Technology Showcase on Tuesday, April 26 in Albuquerque, NM. CEO, Wayne Laslie and team will be at the company’s booth to talk to interested parties about Zocere’s innovative technology and provide updates. More info about the event below: Innovate New Mexico Technology (continued…)


POSTED: March 23, 2016

Zocere Inventor Wins Innovation Award

ALBUQUERQUE, N.M., March 23, 2016 – – Zocere, Inc., a New Mexico-based pharmaceutical company congratulates Dr. Surojit Paul on Innovation Award from STC.UNM. Dr. Paul is the inventor behind Zocere’s biologic-based “brain saving” drug and was honored for his research by the University of New Mexico and STC.UNM. His innovation, memorialized (continued…)


POSTED: July 17, 2015

Zocere’s “Brain Saving” Drug Issued U.S. Patent

ALBUQUERQUE, N.M., July 15, 2015 – – Zocere, Inc., a New Mexico-based pharmaceutical company announces issuance of U.S. Patent No. 9,068,172 for its biologic-based “brain saving” drug. Derived from a STEP protein, the drug is a cell-permeable, recombinant peptide that shows promise as a potent neuroprotectant when administered post stroke. (continued…)


POSTED: January 6, 2015

Zocere to Present Brain-Protecting Drug at Biotech Showcase

SAN FRANCISCO, January 7, 2015 – – Each year, there are an estimated 800,000 acute ischemic strokes in the United States and more than two million worldwide, causing severe damage to the victim’s brain that often results in disability and even death. What’s troubling is that there is just one (continued…)


POSTED: December 12, 2014

CEO/CFO Magazine Goes One-on-One with Zocere’s Wayne Laslie

The editors of CEO/CFO Magazine went one-on-one with Zocere CEO Wayne Laslie for an inside look at the company neuroprotectant drug candidate for stroke, its market potential, commercialization strategy, and an update on fundraising. Read the article>  


POSTED: November 14, 2014

Zocere to Present at Landmark Angels’ Investing for Cures: 2020 Foresight

NEW YORK CITY, November 14, 2014 – – Zocere, Inc., a New Mexico-based pharmaceutical company developing a biologic-based neuroprotectant drug for ischemic stroke, will be presenting at Investing for Cures: 2020 Foresight in New York Wednesday, November 19. Hosted by Greenwich, Connecticut-based Landmark Angels, a private angel investment group, Investing (continued…)


POSTED: November 14, 2014

Zocere Showcases “Brain Saving” Drug at Life Sciences Summit in New York City

NEW YORK CITY, October 14, 2014 – – It happens all too often; people struck by a “silent killer” that can leave them with permanent disabilities or dead. That silent killer is stroke and each year there are an estimated 750,000 acute ischemic strokes in the United States and more (continued…)


POSTED: September 30, 2014

Zocere’s Laslie to Present Stroke Drug at BIO Investor Forum

SAN FRANCISCO, October 1, 2014 – – Each year an estimated 750,000 American suffer an acute ischemic stroke yet only three to five percent receive pharmacologic treatment because of risks associated with current therapies. New Mexico-based pharmaceutical company Zocere has a “brain protecting” drug it believes has the potential to (continued…)


POSTED: September 30, 2014

Zocere to Showcase Novel Neuroprotectant Drug at RESI

BOSTON, September 15, 2014 – – Zocere, Inc., a New Mexico-based pharmaceutical company developing a biologic-based neuroprotectant drug, will be attending the RESI Conference in Boston September 17. The ongoing conference series was created to redefine early stage investments (RESI) by assisting early stage life sciences companies with identifying investors, (continued…)


POSTED: April 17, 2014

Zocere Given Top Innovator Award by youngStartup Ventures

NEW YORK CITY, N.Y., April 17, 2014 – – youngStartup Ventures has presented Zocere, Inc., a New Mexico-based pharmaceutical company developing a novel, biologic-based neuroprotectant drug, with its Top Innovator Award, which recognizes private companies driving the future of innovation. The award was given at the 2014 Life Sciences & (continued…)